DiscoverBeyond the Peloton PodcastVuelta a España Check-In: How is Equipo Kern Pharma Outperforming WorldTour Teams?
Vuelta a España Check-In: How is Equipo Kern Pharma Outperforming WorldTour Teams?

Vuelta a España Check-In: How is Equipo Kern Pharma Outperforming WorldTour Teams?

Update: 2024-09-07
Share

Description

Spencer Martin of the Beyond the Peloton Newsletter and Andrew Vontz of the Choose the Hard Way Podcast/The Better Lab break down the ongoing Vuelta a España, how a small second-division team is better at finding talent than Ineos, and if Primož Roglič will win his fourth career overall title.


BTP In-Depth Daily Vuelta a España Breakdowns


Listen to Andrew's Choose the Hard Way Podcast


BTP is seamlessly following every twist and turn of the 2024 Tour de France with the fantastic Tour Tracker app (iPhone/Android/Web)


Hit up Andrew (@vontz) on Twitter/X & Spencer (@spencersoward) on Threads with your questions, opinions, and anything else cycling-related

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Vuelta a España Check-In: How is Equipo Kern Pharma Outperforming WorldTour Teams?

Vuelta a España Check-In: How is Equipo Kern Pharma Outperforming WorldTour Teams?

BTPPodcast